Bioventus Inc. Research And Development Expense

• Bioventus Inc. showed a decrease of -13.2% in Research And Development Expense from 2024 to 2025.
• This data is from Bioventus Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), Bioventus Inc.'s Research And Development Expense has grown by 9.6%.
• Historical annual values: Fiscal year 2025: $12.11 million | Fiscal year 2024: $13.95 million | Fiscal year 2023: $13.45 million | Fiscal year 2022: $23.85 million | Fiscal year 2021: $19.04 million | Fiscal year 2020: $11.20 million | Fiscal year 2019: $11.06 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026